Mustang Bio, Inc.

Pharmaceutical company · Waltham, Massachusetts, United States · Nasdaq: MBIO

Mustang Bio, Inc. is a pharmaceutical company headquartered in Waltham, Massachusetts, United States. Its earliest recorded incorporation is in 2015. Its shares trade on Nasdaq under the ticker MBIO. It has received 1 US government small-business research award (SBIR/STTR) from health agencies, $2 million in total, most recently in 2021. It has reported private securities offerings to the US SEC, most recently $2.5 million sold in a notice filed in 2024.

Profile compiled from public records. Is this your company? Request a correction or update

Mustang Bio at a glance

Typepharmaceutical company
HeadquartersWaltham, Massachusetts, United States
Earliest incorporation on record2015
Stock listingNasdaq: MBIO
SEC industryPharmaceutical Preparations
Employees (per SBIR records)65
SEC CIK1680048

What does Mustang Bio do?

US government research funding

1 SBIR/STTR small-business research award from US health agencies, $2 million in total (2021). NIH funding came from the National Cancer Institute.

Private fundraising reported to the SEC

9 Form D notices; the most recent reported $2.5 million sold (2024).

Frequently asked questions about Mustang Bio

Where is Mustang Bio headquartered?

Mustang Bio, Inc. is headquartered in Waltham, Massachusetts, United States.

What does Mustang Bio do?

Mustang Bio, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.

Is Mustang Bio a public company?

Yes. Mustang Bio, Inc. trades on Nasdaq under the ticker MBIO.

When was Mustang Bio founded?

The earliest incorporation on record for Mustang Bio, Inc. is in 2015, according to public company registers.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Sources

Location data: GeoNames (geonames.org), CC BY 4.0.

Last updated 2026-09-23.